Ani Pharmaceuticals (ANIP) Gross Margin (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Gross Margin of 60.59% for Q1 2026, up 1.98% sequentially from 59.42% in Q4 2025, and down 236.0% YoY from 44.55% in Q1 2025.
Ani Pharmaceuticals (ANIP) Gross Margin (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Gross Margin for 15 years, with the latest figure at 60.59% in Q1 2026.
- Quarterly Gross Margin fell 236.0% year-over-year to 60.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60.83% (up 149.0% YoY) and the FY2025 annual result came in at 61.36%, up 209.0% from the prior year.
- Gross Margin grew to 60.59% in Q1 2026 per ANIP's latest filing, from 59.42% in the prior quarter.
- Over five years, Gross Margin peaked at 64.7% in Q2 2025 and troughed at 46.85% in Q1 2022.
- A 5-year average of 59.83% and a median of 60.59% in 2026 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2024: Gross Margin soared 12529 bps in 2022, then slumped 604 bps in 2024.
- Over 5 years, Gross Margin stood at 61.45% in 2022, then retreated by 3 bps to 59.42% in 2023, then slipped by 3 bps to 57.87% in 2024, then climbed by 3 bps to 59.42% in 2025, then climbed by 2 bps to 60.59% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 60.59%, 59.42%, and 59.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 62.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.35% |
| Mar 31, 2026 | 60.59% |
| Dec 31, 2025 | 59.42% |
| Sep 30, 2025 | 59.01% |
| Jun 30, 2025 | 64.70% |
| Mar 31, 2025 | 62.95% |
| Dec 31, 2024 | 57.87% |
| Sep 30, 2024 | 57.48% |
| Jun 30, 2024 | 58.20% |
| Mar 31, 2024 | 64.23% |
| Dec 31, 2023 | 59.42% |
| Sep 30, 2023 | 63.51% |
| Jun 30, 2023 | 63.72% |
| Mar 31, 2023 | 64.69% |
| Dec 31, 2022 | 61.45% |
| Sep 30, 2022 | 60.76% |
| Jun 30, 2022 | 52.21% |
| Mar 31, 2022 | 46.85% |
| Dec 31, 2021 | 44.36% |
| Sep 30, 2021 | 53.11% |